Docetaxel Consolidation Therapy Following Cisplatin, Vinorelbine, and Concurrent Thoracic Radiotherapy in Patients with Unresectable Stage III Non-small Cell Lung Cancer
Ikuo Sekine(University of Tsukuba), Tomohide Tamura(St. Luke's International Hospital), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Kiyoshi Mori(Columbia University), Satoshi Ishikura(National Cancer Center Hospital East), Yutaka Nishiwaki(National Cancer Center Hospital East), Iwao Tsukiyama, Nagahiro Saijo(National Cancer Center Hospital East), Hiroshi Nokihara(Tokushima University Hospital)
Cited by 33
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Association between Increases in Urinary Neutrophil Gelatinase–associated Lipocalin and Acute Renal Dysfunction after Adult Cardiac Surgery
|Anesthesiology|2006|570
CT-guided needle biopsy of lung lesions: A survey of severe complication based on 9783 biopsies in Japan
|European Journal of Radiology|2006|499